ZS PHARMA, INC.

Profile

Company Names

ZS PHARMA, INC.

Addresses

508 WRANGLER DRIVE, SUITE 100, COPPELL, TX 75019

1120 SOUTH FREEWAY, FORT WORTH, TX 76104

3601 SAGAMORE PARKWAY NORTH, SUITE B, LAFAYETTE, IN 47904

Phone Numbers

(877) 700-0240
817.727.4150
(765) 742-4813 X205

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2008

State Incorporated:

DE

Total Amount Raised:

$60,175,298.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2014-02-28 
$25,000,000.00 
$25,000,000.00 
$0.00 
Equity 
5
2012-10-09 
$27,600,001.00 
$46,000,000.00 
$18,399,999.00 
Equity 
4
2011-11-10 
$5,305,000.00 
$5,305,000.00 
$0.00 
Equity, Debt 
3
2010-11-01 
$792,000.00 
INDEFINITE 
INDEFINITE 
Equity 
2
2009-02-24 
$1,195,972.00 
$3,000,000.00 
$1,804,028.00 
Equity 
1
2009-02-04 
$282,325.00 
$3,000,000.00 
$2,717,675.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
STEPHEN 
ASH 
EXECUTIVE OFFICER
STEPHEN 
R. 
ASH 
EXECUTIVE OFFICER
JOY 
 
BARTON 
EXECUTIVE OFFICER
NELS 
 
BERGMARK 
EXECUTIVE OFFICER
NELS 
P. 
BERGMARK 
EXECUTIVE OFFICER
TODD 
 
CREECH 
EXECUTIVE OFFICER
MILES 
B. 
DAVIS 
DIRECTOR
ALVARO 
GUILLEM 
EXECUTIVE OFFICER, DIRECTOR
ALVARO 
F. 
GUILLEM 
EXECUTIVE OFFICER, DIRECTOR
DONALD 
JEFFERY 
KEYSER 
EXECUTIVE OFFICER, DIRECTOR
DONALD 
JEFFREY 
KEYSER 
EXECUTIVE OFFICER, DIRECTOR
WILLIAM 
 
KUSHNER 
EXECUTIVE OFFICER
TIM 
 
OPLER 
EXECUTIVE OFFICER, DIRECTOR
MARC 
 
OSTRO 
DIRECTOR
HENRICK 
SANDVAD 
RASMUSSEN 
EXECUTIVE OFFICER
HENRIK 
SANDVAD 
RASMUSSEN 
EXECUTIVE OFFICER
CYNTHIA 
 
SMITH 
EXECUTIVE OFFICER
ROBERT 
TRUITT 
EXECUTIVE OFFICER, DIRECTOR
ROBERT 
B. 
TRUITT 
DIRECTOR, EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-02-28 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-10-09 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2011-11-10 
D/A
PHARMACEUTICALS 
 
NO REVENUES 
Equity, Debt 
2011-11-10 
D
PHARMACEUTICALS 
 
NO REVENUES 
Equity, Debt 
2011-11-10 
D
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2010-11-01 
D/A
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2009-02-24 
D
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2009-02-04 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
SALEM PARTNERS LLC
NONE
NONE
N/A
NONE